Blue test tubes arranged in a line, disappearing into the background

Drug news

NICE does not recommend Avastin (Roche) as a treatment for Ovarian Cancer

Read time: 1 mins

Last updated:19th Dec 2012

Published:19th Dec 2012

Source: Pharmawand

The National Institute for Health and Clinical Excellence (NICE) has published draft guidance on the use of Avastin(bevacizumab) from Roche, as a treatment for women with advanced Ovarian Cancer. The draft guidance does not recommend the use of bevacizumab when used with paclitaxel and carboplatin for people with advanced disease, as a cost-effective treatment for the National Health Service.

Doctor holding patients hand in consultation

Learning Zone

Supportive care in oncology Learning Zone

Supportive care in oncology from a multidisciplinary team involves caring for patients with cancer, treatment adherence and adverse effect management.

How do you prefer to access medical updates and information?

Listen to a podcast

Watch a video

Read an article

Other

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Related news and insights

Drug news

Tagrisso Reinforced as EGFR Lung Cancer Therapy

New study results reinforce Tagrisso as the backbone therapy for EGFR-mutated lung cancer across stages.

7 mins

Drug news

Tolebrutinib Gets FDA Priority Review

Tolebrutinib regulatory submission accepted for priority review by FDA for multiple sclerosis patients.

2 min

Drug news

Refocus-ALZ Fails to Meet Key Endpoints

Topline data indicate Refocus-ALZ did not meet primary, secondary, or exploratory biomarker endpoints.

1 min

See all news